Voyager Therapeutics, Inc. (VYGR)
NASDAQ: VYGR · IEX Real-Time Price · USD
8.37
-0.06 (-0.71%)
At close: Jul 19, 2024, 4:00 PM
8.45
+0.08 (0.96%)
Pre-market: Jul 22, 2024, 7:00 AM EDT
Voyager Therapeutics Stock Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for VYGR stock have an average target of 18, with a low estimate of 8.00 and a high estimate of 30. The average target predicts an increase of 115.05% from the current stock price of 8.37.
Analyst Consensus: Strong Buy
* Price targets were last updated on May 16, 2024.
Analyst Ratings
The average analyst rating for VYGR stock from 6 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
---|---|---|---|---|---|---|
Strong Buy | 2 | 5 | 5 | 3 | 3 | 3 |
Buy | 2 | 2 | 2 | 2 | 2 | 2 |
Hold | 0 | 0 | 0 | 1 | 1 | 1 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 4 | 7 | 7 | 6 | 6 | 6 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $30 | Strong Buy | Reiterates | $30 | +258.42% | May 16, 2024 |
Oppenheimer | Oppenheimer | Buy Maintains $18 | Buy | Maintains | $18 | +115.05% | May 15, 2024 |
Wedbush | Wedbush | Hold Maintains $10 → $8 | Hold | Maintains | $10 → $8 | -4.42% | May 14, 2024 |
Guggenheim | Guggenheim | Strong Buy Initiates $22 | Strong Buy | Initiates | $22 | +162.84% | Mar 26, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $30 | Strong Buy | Initiates | $30 | +258.42% | Mar 19, 2024 |
Financial Forecast
Revenue This Year
49.48M
from 250.01M
Decreased by -80.21%
Revenue Next Year
52.89M
from 49.48M
Increased by 6.88%
EPS This Year
-1.54
from 2.97
EPS Next Year
-1.71
from -1.54
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 77.5M | 167.0M | 129.0M | 129.0M | 347.4M |
Avg | 49.5M | 52.9M | 55.3M | 62.6M | 94.6M |
Low | 32.8M | n/a | n/a | n/a | n/a |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | -69.0% | 237.6% | 143.8% | 133.0% | 454.8% |
Avg | -80.2% | 6.9% | 4.7% | 13.1% | 51.1% |
Low | -86.9% | - | - | - | - |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | -1.06 | 0.06 | -0.88 | -1.07 | 3.63 |
Avg | -1.54 | -1.71 | -1.52 | -1.15 | -0.09 |
Low | -1.95 | -3.08 | -2.21 | -1.32 | -1.64 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | - | - | - | - | - |
Avg | - | - | - | - | - |
Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.